147 related articles for article (PubMed ID: 24623337)
21. Paratesticular papillary serous cystadenocarcinoma--a case report.
Kurian RR; Prema NS; Belthazar A
Indian J Pathol Microbiol; 2006 Jan; 49(1):36-7. PubMed ID: 16625973
[TBL] [Abstract][Full Text] [Related]
22. Endometrioid like yolk sac tumor of the testis with small teratomatous foci: A case report and review of the literature.
Hazarika P
Indian J Pathol Microbiol; 2015; 58(4):557-9. PubMed ID: 26549093
[TBL] [Abstract][Full Text] [Related]
23. HMGA2 is commonly expressed in uterine serous carcinomas and is a useful adjunct to diagnosis.
McCluggage WG; Connolly LE; McBride HA; Kalloger S; Gilks CB
Histopathology; 2012 Mar; 60(4):547-53. PubMed ID: 22250726
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
Soslow RA; Wethington SL; Cesari M; Chiappetta D; Olvera N; Shia J; Levine DA
Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767
[TBL] [Abstract][Full Text] [Related]
25. Primary mucinous tumors of the testis and paratestis: a report of nine cases.
Ulbright TM; Young RH
Am J Surg Pathol; 2003 Sep; 27(9):1221-8. PubMed ID: 12960806
[TBL] [Abstract][Full Text] [Related]
26. Atypical proliferative endometrioid tumor of ovary: Report of a rare case.
Jetley S; Khetrapal S; Ahmad A; Jairajpuri ZS
J Postgrad Med; 2016; 62(2):129-32. PubMed ID: 26497398
[TBL] [Abstract][Full Text] [Related]
27. The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy.
Chui MH; Ryan P; Radigan J; Ferguson SE; Pollett A; Aronson M; Semotiuk K; Holter S; Sy K; Kwon JS; Soma A; Singh N; Gallinger S; Shaw P; Arseneau J; Foulkes WD; Gilks CB; Clarke BA
Am J Surg Pathol; 2014 Sep; 38(9):1173-81. PubMed ID: 25025451
[TBL] [Abstract][Full Text] [Related]
28. Endometrioid neoplasms with clear cells: a report of 21 cases in which the alteration is not of typical secretory type.
Silva EG; Young RH
Am J Surg Pathol; 2007 Aug; 31(8):1203-8. PubMed ID: 17667544
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
McCluggage WG; Young RH
Semin Diagn Pathol; 2005 Feb; 22(1):3-32. PubMed ID: 16512597
[TBL] [Abstract][Full Text] [Related]
30. Ovarian tumors of borderline malignancy (tumors of low malignant potential): a critical appraisal.
Prat J
Adv Anat Pathol; 1999 Sep; 6(5):247-74. PubMed ID: 10472378
[TBL] [Abstract][Full Text] [Related]
31. High-grade Endometrioid Carcinoma of the Ovary: A Clinicopathologic Study of 30 Cases.
Assem H; Rambau PF; Lee S; Ogilvie T; Sienko A; Kelemen LE; Köbel M
Am J Surg Pathol; 2018 Apr; 42(4):534-544. PubMed ID: 29309296
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma.
Madore J; Ren F; Filali-Mouhim A; Sanchez L; Köbel M; Tonin PN; Huntsman D; Provencher DM; Mes-Masson AM
J Pathol; 2010 Feb; 220(3):392-400. PubMed ID: 19967725
[TBL] [Abstract][Full Text] [Related]
33. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.
Zhao C; Bratthauer GL; Barner R; Vang R
Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771
[TBL] [Abstract][Full Text] [Related]
34. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
[TBL] [Abstract][Full Text] [Related]
35. [Papillary cystadenoma: a rare differential diagnosis of a paratesticular tumour].
Dräger DL; Zonnur S; Erbersdobler A; Protzel C; Hakenberg OW
Aktuelle Urol; 2018 Jun; 49(3):262-265. PubMed ID: 28511230
[TBL] [Abstract][Full Text] [Related]
36. Borderline serous papillary tumour of the testis: a case report and review of the literature.
Ibrahim AS; Li C; Al-Jafari MS
Anticancer Res; 2012 Nov; 32(11):5011-3. PubMed ID: 23155272
[TBL] [Abstract][Full Text] [Related]
37. A diagnostic dilemma: dystrophic calcified nodule of the testicle in a patient with no other symptoms - case report and review of the literature.
Viola P; Claudi R; Pompa P; Lattanzio G; Zappacosta R
Urol Int; 2012; 88(2):232-4. PubMed ID: 22248535
[TBL] [Abstract][Full Text] [Related]
38. Paratesticular papillary serous cystadenocarcinoma: a rare entity in Indian population.
Narang V; Sood N; Garg B; Aulakh BS
Indian J Pathol Microbiol; 2014; 57(4):614-6. PubMed ID: 25308020
[TBL] [Abstract][Full Text] [Related]
39. [Immunohistochemical expression of PTEN antigen: a new tool for diagnosis of early endometrial neoplasia].
Taranger-Charpin C; Carpentier S; Dales JP; Garcia S; Djemli A; Andrac L; Lavaut MN; Sferlazzo K; Boubli L
Bull Acad Natl Med; 2004; 188(3):415-27; discussion 427-9. PubMed ID: 15584653
[TBL] [Abstract][Full Text] [Related]
40. Seromucinous ovarian tumor A comparison with the rest of ovarian epithelial tumors.
Karpathiou G; Chauleur C; Corsini T; Venet M; Habougit C; Honeyman F; Forest F; Peoc'h M
Ann Diagn Pathol; 2017 Apr; 27():28-33. PubMed ID: 28325358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]